Arkolith/Insider Trading/ALZN/Form 4

Ault Milton C III

DirectorAlzamend Neuro, Inc. (ALZN) · full profile →Form 4 · filed Oct 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$295K
Net Open-Market Flow
-$295K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 9, 2025Sell(S)20K$2.32$47K8K
Oct 8, 2025Sell(S)101K$2.44$247K29K
Oct 8, 2025Conversion(C)62K$2.32$143K131K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 8, 2025Conversion(C)143$1000.00$143K0

Transaction Codes

S
Open-market sale
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-014861) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML